An Integrated Approach to Pharmacokinetics in Drug Development (description)


Category:Bioscience, Biotechnology, Chemistry, Pharmacology, Pharmacy, Technology/Science
Address:Window Conference Venue, Islington London, , United Kingdom N1 8QG
Phone:+44 20 7193 7703
Event dates:6/28/2010 - 6/29/2010 (This event has already taken place)
Event web site:
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate An Integrated Approach to Pharmacokinetics in Drug Development


Topics to be Covered:

  • Dr Graham Blakey, GBPK Consulting Ltd
Organizer phone:+44 20 7193 7703
Offering type:Workshop
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:
Est. # of exhibitors:
Currency:British Pounds
CE Credits:
Organizer URL


The object of this course is to provide participants with an overview of the principles of Pharmacokinetics and Pharmacokinetic/Pharmacodynamic modelling and how together with regulatory guidances they can be used to effectively deliver drug development programmes. Participants will gain an understanding of the common PK terms and their importance, an understanding of how PK data influences the clinical development programme, an understanding of the factors that contribute to variability in PK, the role of PKPD modelling in drug development , an appreciation of how regulatory guidances influence PK and an increased confidence to discuss PK issues within their drug projects


Day 1: Pharmacokinetic Principles


What is PK and why is it important?

•Absorption, distribution, metabolism and elimination
•Drug failures
•Therapeutic windows
PK terminology

•Clearance, Volume of distribution etc. What are they and what is there importance
PK techniques

•Non compartmental Analysis
•Compartmental modelling
•Population pharmacokinetics
•Regulatory environment
•Data interpretation
Day 2: PK in Drug Development
Pre-clinical/clinical interface

•What PK data are available, how does this influence the Clinical PK strategy?
•Implications for CTA- dose choice and dose escalation in first to man studies, adaptive dosing
Variability in PK

•Drug interactions; CYPs and transporters strategies and regulatory guidance; types of interaction competitive vs mechanism based; implications for study design (restrictions healthy volunteers vs patients etc)
•Genetic polymorphisms

•Study Design
•Regulatory Environment
There will also be several "learning in action" workshops during both days where participants will have the opportunity to apply knowledge gained during the lectures. an open forum session will be held where delegates can bring along their own issues

Registration Fee Details:

Other items that tuition includes:

Travel and hotel arrangements:

Contact Person:Judy Callanan
Organizer Address 1County House
Organizer Address 2221-241 Beckenham Road
Organizer CityBeckenham, Kent
Organizer State/Province: (Outside US)
Organizer Zip or Postal CodeBR3 4UF
Organizer CountryUnited Kingdom
Organizer Phone+44 20 7193 7703
Organizer Fax+44 20 7681 3582
Structural makeupOrganization
Event Site/VenueWindow Conference Venue
Event sold out?No
Multiple locations or dates?Multiple dates but same location
Statistics available for most recent event held in:NA
Average number in event attendance of:
Number in attendance of:
Target BoundariesInternational
Is Registration contact information the same as Organizer Contact above?Yes
Web Page
Can one register for your CE on your web site?Yes
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA

Sign In/Sign Out
About Us
Contact Us